F Wang

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

F Wang, C D Gregory, Clare E. Sample et al. · Journal of Virology · 1990 · 575 citations · Full text

Adaptive Immune System, Immunology, Pathology +18

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

Jeffrey I. Cohen, F Wang, Joan B. Mannick et al. · Proceedings of the National Academy of Sciences · 1989 · 491 citations · Full text

Viral Replication, Lymphocyte Development, Immunology +16

Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity

D Wang, D Liebowitz, F Wang et al. · Journal of Virology · 1988 · 393 citations · Full text

Humoral Response, Immunology, Pathology +20

Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation

Jeffrey I. Cohen, F Wang, Elliott Kieff · Journal of Virology · 1991 · 185 citations · Full text

Viral Replication, Epstein-barr Virus, Natural Sciences +14

Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1

M Franken, Odile Devergne, Michael Rosenzweig et al. · Journal of Virology · 1996 · 93 citations · Full text

Viral Pathogenesis, Immunology, Pathology +16